Condensed Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities
Net (loss) income	$ (40,455)	$ 61,022
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Non-cash royalty revenue	(10,481)	0
Depreciation expense	26	0
Amortization of debt issuance costs and discounts	699	437
Non-cash interest expense related to the revenue interest liability	0	10,937
Non-cash interest expense related to the royalty sale liability	13,090	0
Stock-based compensation expense	2,465	3,235
Changes in assets and liabilities:
Accounts receivable	(1,152)	(6,118)
Prepaids and other assets	(4,925)	(6,590)
Deferred revenue	(3,976)	3,948
Inventories	(4,831)	(7,472)
Accounts payable	27,844	(3,450)
Other accrued liabilities	(932)	(2,121)
Net cash (used in) provided by operating activities	(22,628)	53,828
Investing activities
Purchase of property and equipment	0	(73)
Net cash (used in) investing activities	0	(73)
Financing activities
Payments on revenue interest liability	0	(5,832)
Proceeds from issuance of common stock, net of issuance costs	0	90,672
Proceeds from exercise of warrants, net of issuance costs	0	5,766
Payment of issuance costs	(7,500)	0
Net cash (used in) provided by financing activities	(7,500)	90,606
Net (decrease) increase in cash and cash equivalents	(30,128)	144,361
Cash and cash equivalents at beginning of period	144,761	82,248
Cash and cash equivalents at end of period	114,633	226,609
Supplemental disclosure of cash flow information:
Purchase of property and equipment not yet paid	0	195
Non-cash right of use asset	$ 30	$ 72